Skip to main content
SpringerLink
Log in

The use of new broad spectrum antibiotics

  • Editorial
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sanders CC (1984a) The cephalosporin explosion: the day after. Infect Dis Newsletter 3:27

    Google Scholar 

  2. Rapin M, George C (1983) Management of sepsis. In: J Tinker and M Rapin (eds) Care of the critically ill patient. Springer, Berlin Heidelberg New York

    Google Scholar 

  3. Klastersky J (1983) The role of the new penicillins and cephalosporins in the management of infection in granulocytopenic patients. Schweiz Med Wochenschr 113 (Suppl 14):64

    Google Scholar 

  4. Friis H, Hoffmann S, Hansen M, Mørk-Hansen M, Justesen T, Nissen NI (1983) Cefotaxime versus ampicillin methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy. Acta Med Scand 213:345

    Google Scholar 

  5. Fainstein V, Bodey GP, Elting L, Bolivar R, Keating MJ, McCredie KB, Valdivieso M (1983) A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J Antimicrob Chemother 12 (Suppl A):101

    Google Scholar 

  6. Sanders CC, Sanders WE (1983) Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Rev Infect Dis 5:639

    Google Scholar 

  7. Neu HC (1984) Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk of infection. Am J Med 76:11

    Google Scholar 

  8. Kuck NA, Testa RT, Forbes M (1981) In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics. Antimicrob Agents Chemother 19:634

    Google Scholar 

  9. Wenk M, Vozeh S, Follath F (1984) Serum level monitoring of antibacterial drugs. A review. Clin Pharmacokin 9:475

    Google Scholar 

  10. Moore RD, Smith CR, Lietman PS (1984) The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 149:443

    Google Scholar 

  11. Lerner AM, Cone LA, Jansen W, Reyes MP, Blair DC, Wright GE, Lorber RR (1983) Randomised controlled trial of the comparative efficacy, auditory, toxicity and nephrotoxicity of tobramycin and netilmicin. Lancet 1:1123

    Google Scholar 

  12. Follath F, Borner M, Wenk M, Stalder H, Reber H (1985) Ciprofloxacin therapy in patients with Pseudomonas infections. (Abstract no. 5373) 14th International Congress of Chemotherapy, Kyoto

  13. Sanders CC, Sanders WE, Goering RV, Werner V (1984b) Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 26:797

    Google Scholar 

  14. Kunin CM (1981) Evaluation of antibiotic usage: a comprehensive look at alternative approaches. Rev Infect Dis 3:745

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Department of Medicine, University Hospital, Basel, Switzerland

    F. Follath

Authors
  1. F. Follath
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Follath, F. The use of new broad spectrum antibiotics. Intensive Care Med 11, 277–279 (1985). https://doi.org/10.1007/BF00273535

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00273535

Search

Navigation